BSE - Delayed Quote INR

Lotus Eye Hospital and Institute Limited (LOTUSEYE.BO)

Compare
70.68
+0.33
+(0.47%)
At close: 3:47:45 PM GMT+5:30

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in INR.
NameTitlePayExercisedYear Born
Dr. Kuttapalayam Songappan Ramalingam M.D. CEO & Executive Director -- -- 1950
Mr. Ramanujam Reghunathan Chief Financial Officer -- -- 1957
Mr. Mohanmenon Achuth Menon Company Secretary & Compliance Officer -- -- --
Ms. Sangeetha Sundaramoorthy MD & Director -- -- 1978
Dr. Rajkumar Sundaramoorthy Vice President of Administration -- -- --

Lotus Eye Hospital and Institute Limited

SF No. 770/12, Avinashi Road
Civil Aerodrome Post
Coimbatore, 641014
India
91 42 2422 9900 https://www.lotuseye.org
Sector: 
Healthcare
Full Time Employees: 
336

Description

Lotus Eye Hospital and Institute Limited, a specialty eye care hospital, provides eye care and related services in India. The company offers ReLEx SMILE lasik, touch free laser, lasik eye surgery, epilasik, intralase, supracor, robotic femto laser cataract surgery, phacoemulsification, paediatric eye care and squint surgery, and micro incision cataract surgery treatments. It also provides epizyoptix, special kertometer, and synaptophore; SICS, Phaco, MICS, LRCS, SFLOL, and SF IOL cataract surgery; corneal patchgraft, scleral repair, scrapping + AMG, suture, tatooing, tear suturing, and drop removal; pertygium, C3R, penetrating keratoplasty, TPK and DALK, and DASE; membrane peeling and endolaser; ERM removal, silicon oil and removal, vitrectomy lavage, FGE and C3F8, LPFC and CYCLO CRYO, and scleral buckling and belt buckle; ivta, avastin, razumab, ozurdex, zybev, eyelea, lucentis, and accentrix injections; trabeculectomy; and enucleation, evisceration, DCR and DCT, PTOSIS, and lateral tarsorrhaphy services. In addition, the company offers services in the areas of refractive, cataract, cornea infections, ocular prosthesis, orbit and oculoplasty, glaucoma, keratoconus, computer vision syndrome, neuro ophthalmology, retinal disease/diabetic eye care, uvea and ocular inflammation, zyoptix ultimate, and binocular vision. Further, it operates an eye bank, optical showroom, pharmacy, and research trust; and offers a Bachelor of Science degree in optometry, various optical fellowship courses, and a DNB program. The company was formerly known as Lotus Eye Care Hospital Limited and changed its name to Lotus Eye Hospital and Institute Limited in April 2013. Lotus Eye Hospital and Institute Limited was founded in 1989 and is based in Coimbatore, India.

Corporate Governance

Lotus Eye Hospital and Institute Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

February 12, 2025 at 10:59 AM UTC - February 17, 2025 at 12:00 PM UTC

Lotus Eye Hospital and Institute Limited Earnings Date

Recent Events

September 18, 2023 at 12:00 AM UTC

Ex-Dividend Date

Related Tickers